What does EIFELER APOTHEKE do?

EIFELER APOTHEKE is a pharmacy in Büllingen. Private Limited, started on 3 March 2016, 1 establishment.

What is the address of EIFELER APOTHEKE?

The registered office of EIFELER APOTHEKE is located at Manderfeld 186, 4760 Büllingen.

Is EIFELER APOTHEKE still active?

Yes. According to the CBE (30 October 2026) EIFELER APOTHEKE is active, legal situation “Normale toestand”, started on 3 March 2016.

Is EIFELER APOTHEKE registered on Peppol?

Yes, EIFELER APOTHEKE is registered on the Peppol network with ID 0208:0649933751.

What is the enterprise number of EIFELER APOTHEKE?

The enterprise number of EIFELER APOTHEKE is BE0649933751.

When was EIFELER APOTHEKE founded?

EIFELER APOTHEKE was founded on 3 March 2016.

Who are the directors of EIFELER APOTHEKE?

According to the 2025 annual accounts, the directors of EIFELER APOTHEKE are: Carolien Wydoodt.

Is EIFELER APOTHEKE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 March 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did EIFELER APOTHEKE make in 2025?

EIFELER APOTHEKE posted a profit after taxes of € 63,320 in financial year 2025.

What is the revenue of EIFELER APOTHEKE?

As a small company, EIFELER APOTHEKE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 145,956.

EIFELER APOTHEKE (Private Limited) - Büllingen

Dossier EIFELER APOTHEKE, printed on 30 October 2026 from databakkes.be/en/0649933751/eifeler-apotheke. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EIFELER APOTHEKE from Büllingen, company number BE0649933751, closed financial year 2025 with a result of € 63,320 after tax. For that financial year EIFELER APOTHEKE recorded a gross margin of € 145,956 and equity of € 453,460. Compared with financial year 2024, the result moved from € 68,229 to € 63,320. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 453,460

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 63,320

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 180,311

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 434,860.

People and assets in 2025

Wage cost

€ 25,144

▲ € 24,731 vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,045

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 14,707

▼ 75% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 57,371

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,349

▲ 52% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 130,935 Gross margin 2022: € 130,935 First fiscal year in the series	€ 136,046 Gross margin 2023: € 136,046 ▲ 4% vs 2022 (€ 130,935) Favourable step	€ 136,808 Gross margin 2024: € 136,808 ▲ 1% vs 2023 (€ 136,046) Favourable step	€ 145,956 Gross margin 2025: € 145,956 ▲ 7% vs 2024 (€ 136,808) Favourable step	▲ 7%
Profit after taxes	€ 59,521 Profit after taxes 2022: € 59,521 First fiscal year in the series	€ 54,301 Profit after taxes 2023: € 54,301 ▼ 9% vs 2022 (€ 59,521) Unfavourable step	€ 68,229 Profit after taxes 2024: € 68,229 ▲ 26% vs 2023 (€ 54,301) Favourable step	€ 63,320 Profit after taxes 2025: € 63,320 ▼ 7% vs 2024 (€ 68,229) Unfavourable step	▼ 7%
Equity	€ 306,111 Equity 2022: € 306,111 First fiscal year in the series	€ 343,912 Equity 2023: € 343,912 ▲ 12% vs 2022 (€ 306,111) Favourable step	€ 391,640 Equity 2024: € 391,640 ▲ 14% vs 2023 (€ 343,912) Favourable step	€ 453,460 Equity 2025: € 453,460 ▲ 16% vs 2024 (€ 391,640) Favourable step	▲ 16%
Total debts	€ 230,340 Total debts 2022: € 230,340 First fiscal year in the series	€ 171,243 Total debts 2023: € 171,243 ▼ 26% vs 2022 (€ 230,340) Favourable step	€ 147,191 Total debts 2024: € 147,191 ▼ 14% vs 2023 (€ 171,243) Favourable step	€ 85,018 Total debts 2025: € 85,018 ▼ 42% vs 2024 (€ 147,191) Favourable step	▼ 42%
Cash	€ 200,310 Cash 2022: € 200,310 First fiscal year in the series	€ 227,300 Cash 2023: € 227,300 ▲ 13% vs 2022 (€ 200,310) Favourable step	€ 154,472 Cash 2024: € 154,472 ▼ 32% vs 2023 (€ 227,300) Unfavourable step	€ 180,311 Cash 2025: € 180,311 ▲ 17% vs 2024 (€ 154,472) Favourable step	▲ 17%
Land & buildings	€ 13,920 Land & buildings 2022: € 13,920 First fiscal year in the series	€ 15,128 Land & buildings 2023: € 15,128 ▲ 9% vs 2022 (€ 13,920) Unchanged	€ 15,486 Land & buildings 2024: € 15,486 ▲ 2% vs 2023 (€ 15,128) Unchanged	€ 12,117 Land & buildings 2025: € 12,117 ▼ 22% vs 2024 (€ 15,486) Unchanged	▼ 22%
Retained profit	€ 287,511 Retained profit 2022: € 287,511 First fiscal year in the series	€ 325,312 Retained profit 2023: € 325,312 ▲ 13% vs 2022 (€ 287,511) Favourable step	€ 373,040 Retained profit 2024: € 373,040 ▲ 15% vs 2023 (€ 325,312) Favourable step	€ 434,860 Retained profit 2025: € 434,860 ▲ 17% vs 2024 (€ 373,040) Favourable step	▲ 17%
Dividend	€ 17,000 Dividend 2022: € 17,000 First fiscal year in the series	€ 16,500 Dividend 2023: € 16,500 ▼ 3% vs 2022 (€ 17,000) Unchanged	€ 20,500 Dividend 2024: € 20,500 ▲ 24% vs 2023 (€ 16,500) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 20,500) Unchanged	▼ 100%
Bank debt	€ 143,510 Bank debt 2022: € 143,510 First fiscal year in the series	€ 101,279 Bank debt 2023: € 101,279 ▼ 29% vs 2022 (€ 143,510) Favourable step	€ 58,348 Bank debt 2024: € 58,348 ▼ 42% vs 2023 (€ 101,279) Favourable step	€ 14,707 Bank debt 2025: € 14,707 ▼ 75% vs 2024 (€ 58,348) Favourable step	▼ 75%
Balance sheet total	€ 536,450 Balance sheet total 2022: € 536,450 First fiscal year in the series	€ 515,155 Balance sheet total 2023: € 515,155 ▼ 4% vs 2022 (€ 536,450) Unchanged	€ 538,832 Balance sheet total 2024: € 538,832 ▲ 5% vs 2023 (€ 515,155) Unchanged	€ 538,478 Balance sheet total 2025: € 538,478 Unchanged (€ 538,832) Unchanged
Employees (FTE)	0.5 Employees (FTE) 2022: 0.5 First fiscal year in the series	0.2 Employees (FTE) 2023: 0.2 ▼ 0.3 vs 2022 (0.5) Unchanged	-	-

Key figures of EIFELER APOTHEKE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EIFELER APOTHEKE?

What happened at EIFELER APOTHEKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 63,320 (▼ 7% vs 2024). Source: NBB ↗
Mar 15, 2016 New establishment in Büllingen. KBO
2016 Carolien Wydoodt became a director. NBB
Mar 3, 2016 Start of the company according to the CBE. KBO

In short

From € 59,521 profit in 2022 to € 63,320 profit in 2025.

Paid € 71,040 in corporate taxes since 2022.

Best year ever: 2024, with € 68,229 profit.

Paid out € 54,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Carolien Wydoodt

EIFELER APOTHEKE

Behind EIFELER APOTHEKE is Carolien Wydoodt.

Directors

According to the 2025 annual accounts

Carolien Wydoodt

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Manderfeld 186

4760 Büllingen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0649.933.751

VAT number

BE 0649.933.751

Registered office

Manderfeld 186, 4760 Büllingen

Names & denominations

EIFELER APOTHEKE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 March 2016

Peppol

Active · Active since 2 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

Detailhandel in cosmetica en toiletartikelen

Groothandel in andere voedingsmiddelen, neg

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

EIFELER APOTHEKE

Financials

What happened to EIFELER APOTHEKE?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions